<p class="MsoNormal"><span style="color:#333333">CureVac sold more than 13.3 million shares to raise $213.3 million in the initial public offering (IPO). According to data compiled by Bloomberg, it was the best first-day performance among 200 new listings on US exchanges this year.</span></p>
